Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.1M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$34.8M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$33.2M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$30.7M |
| 5 |
DaVita
DVA
|
+$30.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$170M |
| 2 |
STJ
St Jude Medical
STJ
|
+$40.7M |
| 3 |
Danaher
DHR
|
+$37.7M |
| 4 |
Mettler-Toledo International
MTD
|
+$34M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.81% |
| 2 | Consumer Discretionary | 10.65% |
| 3 | Industrials | 10.41% |
| 4 | Healthcare | 10.37% |
| 5 | Technology | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Best Buy
BBY
$18.1B
| $581K | 0.02% |
11,822
-3,178
| -21% | -$142K |
|
602
Unisys
UIS
$200M
| $581K | 0.02% |
41,618
+7,185
| +21% | +$99.6K |
|
|
ARRS
603
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $581K | 0.02% |
21,971
-12,244
| -36% | -$342K |
|
|
BLD
604
DELISTED
TopBuild
BLD
| $580K | 0.02% |
12,350
+6,005
| +95% | +$244K |
|
|
TGNA
605
DELISTED
TEGNA Inc
TGNA
| $579K | 0.02% |
35,328
-43,664
| -55% | -$671K |
|
606
Ares Capital
ARCC
$14.3B
| $577K | 0.02% |
33,217
+16,834
| +103% | +$291K |
|
607
Halliburton
HAL
$29.4B
| $576K | 0.02% |
11,715
-5,654
| -33% | -$304K |
|
608
Snap-on
SNA
$20.3B
| $576K | 0.02% |
3,414
+256
| +8% | +$44K |
|
|
VSI
609
DELISTED
Vitamin Shoppe Inc.
VSI
| $574K | 0.02% |
28,500
+15,700
| +123% | +$335K |
|
610
Western Union
WU
$2.28B
| $573K | 0.02% |
+28,139
| New | +$574K |
|
611
Moog Inc Class A
MOG.A
$12.3B
| $571K | 0.02% |
8,484
-1,378
| -14% | -$91.1K |
|
612
Ormat Technologies
ORA
$6.67B
| $571K | 0.02% |
10,012
+670
| +7% | +$37.1K |
|
613
Synaptics
SYNA
$3.82B
| $567K | 0.02% |
11,458
+5,358
| +88% | +$288K |
|
614
Seres Therapeutics
MCRB
$45.8M
| $566K | 0.02% |
2,509
+1,553
| +162% | +$315K |
|
|
VSTO
615
DELISTED
Vista Outdoor Inc.
VSTO
| $565K | 0.02% |
27,417
+17,481
| +176% | +$432K |
|
616
FerroAtlántica
GSM
$762M
| $564K | 0.02% |
54,608
-1,382
| -2% | -$14.5K |
|
617
NorthWestern Energy
NWE
$4.27B
| $564K | 0.02% |
9,600
+1,200
| +14% | +$68.9K |
|
618
Civeo
CVEO
$357M
| $562K | 0.02% |
15,662
+1,031
| +7% | +$36.7K |
|
619
JELD-WEN Holding
JELD
$200M
| $562K | 0.02% |
+17,100
| New | +$521K |
|
620
United Bankshares
UBSI
$6.51B
| $560K | 0.02% |
13,243
-129,148
| -91% | -$5.69M |
|
621
Arrow Electronics
ARW
$10.7B
| $559K | 0.02% |
7,619
-7,938
| -51% | -$581K |
|
|
DOC
622
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $558K | 0.02% |
+28,084
| New | +$536K |
|
623
ICF International
ICFI
$1.6B
| $556K | 0.02% |
13,471
+5,071
| +60% | +$245K |
|
|
QCP
624
DELISTED
Quality Care Properties, Inc.
QCP
| $556K | 0.02% |
29,461
+9,650
| +49% | +$172K |
|
625
Evertec
EVTC
$1.79B
| $554K | 0.02% |
34,843
+13,048
| +60% | +$222K |
|
Similar funds
Paul Tudor Jones's Q1 2017 Portfolio in Review
As of Q1 2017, Paul Tudor Jones held 1,687 positions worth $3.25B, down 16% from $3.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Paul Tudor Jones withdrew a net $793M in Q1 2017, closing 340 positions and reducing 514 holdings. Its most notable exit was St Jude Medical, an estimated $40.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Paul Tudor Jones opened a new position in iShares MSCI Emerging Markets ETF worth $72.8M.
- Paul Tudor Jones's largest Q1 2017 buy was iShares MSCI Emerging Markets ETF: 1,847,000 shares worth $72.8M.
- Paul Tudor Jones added most to Mead Johnson Nutrition Company in Q1 2017, an estimated $30.7M increase.
- Paul Tudor Jones's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $170M.
- Paul Tudor Jones fully exited St Jude Medical in Q1 2017, selling an estimated $40.7M.
- Paul Tudor Jones's ten largest holdings make up 31% of its $3.25B portfolio in Q1 2017.
- Paul Tudor Jones opened 332 new positions and closed 340 in Q1 2017.
- Paul Tudor Jones's portfolio value fell 16% quarter-over-quarter to $3.25B.
Based on Tudor Investment Corp's 13F filing for Q1 2017, filed 15 May 2017.